VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 355 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2013. The put-call ratio across all filers is 0.61 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $4,239,000 | +140.4% | 182,411 | +64.7% | 0.00% | +200.0% |
| Q1 2018 | $1,763,000 | -62.6% | 110,743 | -51.2% | 0.00% | -66.7% |
| Q4 2017 | $4,716,000 | +751.3% | 226,958 | +487.0% | 0.00% | – |
| Q3 2017 | $554,000 | -78.4% | 38,661 | -73.9% | 0.00% | -100.0% |
| Q2 2017 | $2,560,000 | +485.8% | 147,990 | +273.1% | 0.00% | – |
| Q1 2017 | $437,000 | +13.2% | 39,664 | +49.3% | 0.00% | – |
| Q4 2016 | $386,000 | -52.9% | 26,572 | -20.4% | 0.00% | -100.0% |
| Q3 2016 | $820,000 | +32.0% | 33,389 | +8.3% | 0.00% | 0.0% |
| Q2 2016 | $621,000 | -72.1% | 30,828 | -63.5% | 0.00% | -50.0% |
| Q1 2016 | $2,222,000 | -93.4% | 84,474 | -74.4% | 0.00% | -93.1% |
| Q4 2015 | $33,577,000 | +228.7% | 330,321 | +476.9% | 0.03% | +222.2% |
| Q3 2015 | $10,214,000 | -37.0% | 57,260 | -21.5% | 0.01% | -30.8% |
| Q2 2015 | $16,201,000 | +69.0% | 72,926 | +50.3% | 0.01% | +62.5% |
| Q1 2015 | $9,584,000 | -22.0% | 48,511 | -43.3% | 0.01% | -20.0% |
| Q4 2014 | $12,293,000 | +115.4% | 85,602 | +97.0% | 0.01% | +100.0% |
| Q3 2014 | $5,706,000 | -69.8% | 43,450 | -71.0% | 0.01% | -68.8% |
| Q2 2014 | $18,910,000 | +229.6% | 149,939 | +244.4% | 0.02% | +220.0% |
| Q1 2014 | $5,737,000 | +3.9% | 43,542 | -7.5% | 0.01% | 0.0% |
| Q4 2013 | $5,520,000 | +13.6% | 47,061 | +1.2% | 0.01% | 0.0% |
| Q3 2013 | $4,858,000 | +15.7% | 46,495 | -4.8% | 0.01% | +25.0% |
| Q2 2013 | $4,199,000 | – | 48,850 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,577,892 | $994,984,000 | 31.62% |
| Ruane, Cunniff & Goldfarb | 33,922,192 | $6,051,041,000 | 31.06% |
| LeVasseur Capital Partners LLC | 162,394 | $28,968,000 | 29.76% |
| FARLEY CAPITAL L.P. | 192,130 | $34,272,000 | 27.18% |
| Pershing Square Capital Management | 19,473,933 | $3,473,760,000 | 24.90% |
| Arrow Capital Management, LLC | 109,461 | $19,525,000 | 16.53% |
| Marble Arch Investments | 1,196,900 | $213,503,000 | 16.43% |
| Tesuji Partners | 1,368,040 | $244,414,000 | 15.82% |
| ValueAct Holdings | 14,994,261 | $2,674,676,000 | 15.55% |
| Hound Partners | 3,898,648 | $695,441,000 | 15.04% |